Acorda Therapeutics Inc (ACORQ)
0.85
0.00 (0.00%)
USD |
OTCM |
May 02, 15:59
Acorda Therapeutics Accounts Payable (Quarterly): 14.54M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 14.54M |
September 30, 2023 | 12.33M |
June 30, 2023 | 3.175M |
March 31, 2023 | 2.854M |
December 31, 2022 | 10.09M |
September 30, 2022 | 11.50M |
June 30, 2022 | 7.958M |
March 31, 2022 | 8.768M |
December 31, 2021 | 11.82M |
September 30, 2021 | 15.50M |
June 30, 2021 | 17.48M |
March 31, 2021 | 9.488M |
December 31, 2020 | 13.58M |
September 30, 2020 | 10.36M |
June 30, 2020 | 14.63M |
March 31, 2020 | 12.07M |
December 31, 2019 | 26.84M |
September 30, 2019 | 26.78M |
June 30, 2019 | 26.72M |
March 31, 2019 | 25.96M |
December 31, 2018 | 49.37M |
September 30, 2018 | 29.55M |
June 30, 2018 | 15.40M |
March 31, 2018 | 18.38M |
December 31, 2017 | 31.07M |
Date | Value |
---|---|
September 30, 2017 | 21.74M |
June 30, 2017 | 19.97M |
March 31, 2017 | 21.38M |
December 31, 2016 | 29.91M |
September 30, 2016 | 18.56M |
June 30, 2016 | 29.55M |
March 31, 2016 | 21.36M |
December 31, 2015 | 17.07M |
September 30, 2015 | 14.00M |
June 30, 2015 | 16.95M |
March 31, 2015 | 21.89M |
December 31, 2014 | 20.29M |
September 30, 2014 | 20.51M |
June 30, 2014 | 20.66M |
March 31, 2014 | 21.51M |
December 31, 2013 | 17.98M |
September 30, 2013 | 15.91M |
June 30, 2013 | 21.19M |
March 31, 2013 | 24.08M |
December 31, 2012 | 24.18M |
September 30, 2012 | 18.46M |
June 30, 2012 | 19.72M |
March 31, 2012 | 20.01M |
December 31, 2011 | 23.37M |
September 30, 2011 | 13.94M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
2.854M
Minimum
Mar 2023
26.84M
Maximum
Dec 2019
13.50M
Average
12.07M
Median
Mar 2020
Accounts Payable (Quarterly) Benchmarks
BioSig Technologies Inc | -- |
Verve Therapeutics Inc | 6.636M |
Spectral AI Inc | 3.275M |
AIM ImmunoTech Inc | 6.443M |
Protalix BioTherapeutics Inc | 4.32M |